Enzymatic biochemical parameters (ALT, AST, ALP, γ-GT, LDH) in children with acute lymphoblastic leukemia before antineoplastic treatment
Descripción del Articulo
Objective: To determine the enzymatic biochemical parameters (glutamic pyruvic transaminase (ALT), glutamic oxaloacetic transaminase (AST), alkaline phosphatase (ALP), gamma glutamyltransferase (y-GT), and lactate dehydrogenase (LDH)) in children with acute lymphoblastic leukemia (ALL) before cancer...
Autores: | , |
---|---|
Formato: | artículo |
Fecha de Publicación: | 2015 |
Institución: | Universidad de San Martín de Porres |
Repositorio: | Horizonte médico |
Lenguaje: | español |
OAI Identifier: | oai:horizontemedico.usmp.edu.pe:article/341 |
Enlace del recurso: | https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/341 |
Nivel de acceso: | acceso abierto |
Materia: | ALT AST ALP y-GT LDH Dehydrogenase Acute Lymphatic Leukemia Leucemia Linfoblastica Aguda |
id |
REVHM_249b2e227c0a3f89bd918782fb396e7b |
---|---|
oai_identifier_str |
oai:horizontemedico.usmp.edu.pe:article/341 |
network_acronym_str |
REVHM |
network_name_str |
Horizonte médico |
repository_id_str |
|
dc.title.none.fl_str_mv |
Enzymatic biochemical parameters (ALT, AST, ALP, γ-GT, LDH) in children with acute lymphoblastic leukemia before antineoplastic treatment Parámetros bioquímicos enzimáticos (ALT, AST, ALP, γ-GT, LDH) en niños con leucemia linfoblástica aguda antes del tratamiento antineoplásico |
title |
Enzymatic biochemical parameters (ALT, AST, ALP, γ-GT, LDH) in children with acute lymphoblastic leukemia before antineoplastic treatment |
spellingShingle |
Enzymatic biochemical parameters (ALT, AST, ALP, γ-GT, LDH) in children with acute lymphoblastic leukemia before antineoplastic treatment Moya S., Jeél ALT AST ALP y-GT LDH Dehydrogenase Acute Lymphatic Leukemia ALT AST ALP y-GT LDH Leucemia Linfoblastica Aguda |
title_short |
Enzymatic biochemical parameters (ALT, AST, ALP, γ-GT, LDH) in children with acute lymphoblastic leukemia before antineoplastic treatment |
title_full |
Enzymatic biochemical parameters (ALT, AST, ALP, γ-GT, LDH) in children with acute lymphoblastic leukemia before antineoplastic treatment |
title_fullStr |
Enzymatic biochemical parameters (ALT, AST, ALP, γ-GT, LDH) in children with acute lymphoblastic leukemia before antineoplastic treatment |
title_full_unstemmed |
Enzymatic biochemical parameters (ALT, AST, ALP, γ-GT, LDH) in children with acute lymphoblastic leukemia before antineoplastic treatment |
title_sort |
Enzymatic biochemical parameters (ALT, AST, ALP, γ-GT, LDH) in children with acute lymphoblastic leukemia before antineoplastic treatment |
dc.creator.none.fl_str_mv |
Moya S., Jeél Pio D., Liz |
author |
Moya S., Jeél |
author_facet |
Moya S., Jeél Pio D., Liz |
author_role |
author |
author2 |
Pio D., Liz |
author2_role |
author |
dc.subject.none.fl_str_mv |
ALT AST ALP y-GT LDH Dehydrogenase Acute Lymphatic Leukemia ALT AST ALP y-GT LDH Leucemia Linfoblastica Aguda |
topic |
ALT AST ALP y-GT LDH Dehydrogenase Acute Lymphatic Leukemia ALT AST ALP y-GT LDH Leucemia Linfoblastica Aguda |
description |
Objective: To determine the enzymatic biochemical parameters (glutamic pyruvic transaminase (ALT), glutamic oxaloacetic transaminase (AST), alkaline phosphatase (ALP), gamma glutamyltransferase (y-GT), and lactate dehydrogenase (LDH)) in children with acute lymphoblastic leukemia (ALL) before cancer treatment. Material and Methods: A prospective experimental, observational, cross-sectional study was conducted in 30 children between 2 and 15 years old, from several Neoplastic Centers in Lima. Blood collection was performed in BD red cap Vacutainer tubes, processed in the semi-automated analyzer BIOTEC® EMP-168, with Wiener Lab Group enzyme reagents under the modified method Szaaz and UV-Optimized by IFCC, SSCC and SFBC. Finally, coding and tabulation was performed. Results: 60% were boys and 46.7% are between the ages of 2-6 years. Serum levels of AST were increased by 33.3% in boys and 50% in girls. Serum ALT values were increased in 33.3% of boys and 41.7% of girls; only 25% of girls showed increased levels of y-GT values; ALP was increased in 44.4% of boys and 66.7% of girls. Moreover LDH levels were increased in 55.6% of boys and 41.7% of girls. Conclusion: The enzymatic tests LDH, AST, ALT and ALP are increased in children with ALL compared to normal values due to tumor lysis syndrome characterized by electrolyte abnormalities, and as a result of the massive destruction of tumor cells and rapid release of large amounts of intracellular elements. |
publishDate |
2015 |
dc.date.none.fl_str_mv |
2015-12-14 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/341 10.24265/horizmed.2015.v15n4.08 |
url |
https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/341 |
identifier_str_mv |
10.24265/horizmed.2015.v15n4.08 |
dc.language.none.fl_str_mv |
spa |
language |
spa |
dc.relation.none.fl_str_mv |
https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/341/303 |
dc.rights.none.fl_str_mv |
Derechos de autor 2015 Horizonte Médico (Lima) https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Derechos de autor 2015 Horizonte Médico (Lima) https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Universidad de San Martín de Porres. Facultad de Medicina Humana |
publisher.none.fl_str_mv |
Universidad de San Martín de Porres. Facultad de Medicina Humana |
dc.source.none.fl_str_mv |
Horizonte Médico (Lima); Vol. 15 No. 4 (2015): October - December; 52-58 Horizonte Médico (Lima); Vol. 15 Núm. 4 (2015): Octubre - Diciembre; 52-58 Horizonte Médico (Lima); v. 15 n. 4 (2015): Octubre - Diciembre; 52-58 2227-3530 1727-558X 10.24265/horizmed.2015.v15n4 reponame:Horizonte médico instname:Universidad de San Martín de Porres instacron:USMP |
instname_str |
Universidad de San Martín de Porres |
instacron_str |
USMP |
institution |
USMP |
reponame_str |
Horizonte médico |
collection |
Horizonte médico |
repository.name.fl_str_mv |
|
repository.mail.fl_str_mv |
|
_version_ |
1844720556737298432 |
spelling |
Enzymatic biochemical parameters (ALT, AST, ALP, γ-GT, LDH) in children with acute lymphoblastic leukemia before antineoplastic treatmentParámetros bioquímicos enzimáticos (ALT, AST, ALP, γ-GT, LDH) en niños con leucemia linfoblástica aguda antes del tratamiento antineoplásicoMoya S., JeélPio D., LizALTASTALPy-GTLDHDehydrogenaseAcute Lymphatic LeukemiaALTASTALPy-GTLDHLeucemia Linfoblastica AgudaObjective: To determine the enzymatic biochemical parameters (glutamic pyruvic transaminase (ALT), glutamic oxaloacetic transaminase (AST), alkaline phosphatase (ALP), gamma glutamyltransferase (y-GT), and lactate dehydrogenase (LDH)) in children with acute lymphoblastic leukemia (ALL) before cancer treatment. Material and Methods: A prospective experimental, observational, cross-sectional study was conducted in 30 children between 2 and 15 years old, from several Neoplastic Centers in Lima. Blood collection was performed in BD red cap Vacutainer tubes, processed in the semi-automated analyzer BIOTEC® EMP-168, with Wiener Lab Group enzyme reagents under the modified method Szaaz and UV-Optimized by IFCC, SSCC and SFBC. Finally, coding and tabulation was performed. Results: 60% were boys and 46.7% are between the ages of 2-6 years. Serum levels of AST were increased by 33.3% in boys and 50% in girls. Serum ALT values were increased in 33.3% of boys and 41.7% of girls; only 25% of girls showed increased levels of y-GT values; ALP was increased in 44.4% of boys and 66.7% of girls. Moreover LDH levels were increased in 55.6% of boys and 41.7% of girls. Conclusion: The enzymatic tests LDH, AST, ALT and ALP are increased in children with ALL compared to normal values due to tumor lysis syndrome characterized by electrolyte abnormalities, and as a result of the massive destruction of tumor cells and rapid release of large amounts of intracellular elements.Objetivo: Determinar los parámetros bioquímicos enzimáticos (Transaminasa Glutámico Pirúvica (ALT), Transaminasa Glutámico Oxalacetico (AST), Fosfatasa Alcalina (ALP), Gamma Glutamiltransferasa (y-GT), y Lactato Deshidrogenasa (LDH)) en niños con Leucemia Linfoblástica Aguda (LLA) antes del tratamiento antineoplásico. Material y Métodos: Estudio prospectivo experimental, observacional, de corte transversal, en 30 niños con LLA entre 2 y 15 años, en diversos Centros Neoplásicos de Lima. La colecta sanguínea se realizó en tubos BD Vacutainer® de tapa color rojo, procesados en el analizador semiautomatizado BIOTEC® EMP-168, con reactivos enzimáticos de Wiener Lab Group bajo el método modificado de Szaaz y UV-Optimizado por IFCC, SSCC y SFBC. Por último, se realizó la codificación y tabulación de datos. Resultados: El 60% correspondió a niños y el 46,7% corresponde a las edades entre 2 a 6 años. Los niveles séricos de AST estuvieron incrementados en el 33,3% en niños y el 50% en niñas. Los valores séricos de ALT estuvieron incrementados en el 33,3% de niños y en el 41,7% de niñas; solamente el 25% de niñas presentaron valores incrementados de y-GT; la ALP estuvo acrecentada en el 44,4% de niños y en el 66,7% de niñas. Por otro lado los niveles de LDH estuvieron acrecentados en el 55,6% de niños y en el 41,7% de niñas. Conclusión: Las pruebas enzimáticas LDH, AST, ALT y ALP se encuentran aumentados en niños con LLA con respecto a los valores normales, debido al síndrome de lisis tumoral caracterizada por alteraciones electrolíticas, y como consecuencia de la destrucción masiva de células tumorales y la liberación rápida de grandes cantidades de elementos intracelulares.Universidad de San Martín de Porres. Facultad de Medicina Humana2015-12-14info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/34110.24265/horizmed.2015.v15n4.08Horizonte Médico (Lima); Vol. 15 No. 4 (2015): October - December; 52-58Horizonte Médico (Lima); Vol. 15 Núm. 4 (2015): Octubre - Diciembre; 52-58Horizonte Médico (Lima); v. 15 n. 4 (2015): Octubre - Diciembre; 52-582227-35301727-558X10.24265/horizmed.2015.v15n4reponame:Horizonte médicoinstname:Universidad de San Martín de Porresinstacron:USMPspahttps://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/341/303Derechos de autor 2015 Horizonte Médico (Lima)https://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessoai:horizontemedico.usmp.edu.pe:article/3412022-08-03T18:18:11Z |
score |
13.08006 |
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).